6 years ago
Kheiron Medical Raises €20 Million for AI-Powered Breast Cancer Detection Software
Kheiron Medical Technologies, a London-based medtech startup, has raised €20 million in Series A funding led by Atomico
The company's AI-based breast cancer detection software, Mia, aims to improve outcomes for breast cancer patients by assisting radiologists in making more accurate diagnoses
The funding will be used to scale clinical validation of Mia, including conducting large-scale clinical trials and roll-outs in Europe, the US, and Asia
Kheiron's approach emphasizes rigorous development and testing to ensure improved patient outcomes and safety
Mia has demonstrated state-of-the-art performance in a multi-center clinical study and was voted Best New Radiology Software 2019 by AuntMinnie
The software is being deployed for live testing and further trials with the UK's National Health Service (NHS) and leading academic medical centers in the US.
ProblemHealthcare
"Diagnosing cancer, especially in its early stages, is challenging and time-consuming for radiologists, and the shortage of radiologists coupled with increasing demand for imaging puts immense pressure on doctors responsible for critical patient care decisions."
Solution
"Kheiron provides AI-powered software that analyzes mammography images to assist radiologists in making more accurate diagnoses, particularly in breast cancer screening, aiming to improve early detection rates and patient outcomes."